Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nano-X Imaging (NNOX) Research & Development (2019 - 2025)

Nano-X Imaging filings provide 6 years of Research & Development readings, the most recent being $4.8 million for Q4 2025.

  • On a quarterly basis, Research & Development fell 10.42% to $4.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.2 million, a 4.69% decrease, with the full-year FY2025 number at $19.2 million, down 4.69% from a year prior.
  • Research & Development hit $4.8 million in Q4 2025 for Nano-X Imaging, up from $4.6 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $7.1 million in Q4 2022 to a low of $2.7 million in Q1 2021.
  • Median Research & Development over the past 5 years was $5.3 million (2024), compared with a mean of $5.5 million.
  • Biggest five-year swings in Research & Development: skyrocketed 152.12% in 2022 and later plummeted 30.39% in 2024.
  • Nano-X Imaging's Research & Development stood at $6.4 million in 2021, then grew by 11.52% to $7.1 million in 2022, then decreased by 3.99% to $6.8 million in 2023, then fell by 20.71% to $5.4 million in 2024, then decreased by 10.42% to $4.8 million in 2025.
  • The last three reported values for Research & Development were $4.8 million (Q4 2025), $4.6 million (Q3 2025), and $4.8 million (Q2 2025) per Business Quant data.